December 15, 2024
avatar-torie-bosch
First Opinion editor

This week, First Opinion published an essay that went viral: More than 15 years ago, Wendell Potter went from a PR executive at Cigna to a whistleblower. On Tuesday, he wrote a scathing piece about the health insurance industry: “the relentless profit demands of Wall Street, its growing entanglement in the health care sector, and how it is adversely impacting patient care.” It resonated with many readers, I’m proud to say.

I plan to continue publishing essays on First Opinion about the backlash to the health care industry. But I want to make sure to start focusing on where we go from here. I’m going to continue looking for essays that make sharp, clear proposals for what should happen next. What fixes would actually make a difference in a sprawling, complicated health care system? Critically, what fixes have a chance of being implemented in a fractured political environment? What do people within the industry think that the backlash is getting wrong, and what changes would they like to see? The more specific, the better. I want to see the conversation both on STAT and elsewhere go from anger to idea-generation.

If you have an idea for something along those lines, please reach out: first.opinion@statnews.com.  

Recommendation of the week: I really enjoyed this week’s episode of the health care policy podcast “Tradeoffs,” which featured a nuanced interview with pediatrician and researcher Aaron Carroll about the health insurance industry backlash. Carroll argues that criticism of insurance companies is valid, but that they are just one part of a dysfunctional system. (Disclosure: I donate money to “Tradeoffs” monthly. Remember: Support the media that you find valuable!)

Jamie Foxx with his sister DeOndra Dixon, other family members, and Michelle Sie Whitten
GLOBAL Down Syndrome Foundation

Jamie Foxx calls on the Senate to pass a bill funding Down syndrome research

This unprecedented legislation can improve health care for people with Down syndrome and unlock critical insights into Alzheimer’s, tumors, and more.

By Michelle Sie Whitten and Jamie Foxx


I have a rare form of ALS. I have to fight my insurance company every six months for a game-changing drug

I am once again at the mercy of an insurance system that treats human life as just another line on a balance sheet.

By Shelby Kinsey


In a threat to patient trust, Texas hospitals must ask ‘Are you a U.S. citizen?’

As I prepare to enter medical school, I worry that Texas’ new requirement to ask hospital patients about immigration status threatens future care.

By Akshara Ramasamy



Adobe

STAT+ | What I’ve learned — the hard way — about AI in bio

I’ve learned the five stages of AI grief in techbio the hard way. Here’s what they look like.

By Naren Tallapragada


Inclusive immigration policies protect America’s health care

The 2017 travel ban had a material effect on the U.S. medical system. As a Syrian physician practicing in America, I worry it could happen again.

By M. Ihsan Kaadan


Medical schools need to offer students alternatives to state physician health programs

The way medical schools and state physician health programs handle student mental health crises and concerns about substance abuse is a mess.

By J. Wesley Boyd


Richard Drew/AP

I used to do health insurance company PR. Here’s what I think the backlash is missing

As the former VP of corporate communications at Cigna, I used to protect the health insurance business. Today's public conversation is missing something.

By Wendell Potter


STAT+ | Congress can’t let the year end without renewing the Lorna Breen Act

The Lorna Breen Act, named for a physician who died by suicide, supports health care workers’ mental health. Congress must reauthorize it now.

By Corey Feist and Trina Spear


STAT+ | Mental health apps need a complete redesign

The field of digital mental health has been trying to tackle its engagement problem for years, with little progress. That needs to change.

By Benjamin Kaveladze


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.